AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.
The Cambridge,.
Marché : AstraZeneca rachète le spécialiste des maladies rares Caelum Biosciences tradingsat.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tradingsat.com Daily Mail and Mail on Sunday newspapers.
AstraZeneca rachète le spécialiste des maladies rares Caelum Biosciences challenges.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from challenges.fr Daily Mail and Mail on Sunday newspapers.
AstraZeneca rachète le spécialiste des maladies rares Caelum Biosciences latribune.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from latribune.fr Daily Mail and Mail on Sunday newspapers.